Nourianz (istradefylline)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nourianz (istradefylline), covering 2024-04-25 to 2024-04-25. Get the full timeline:
Most recent: Clinical Trial Update: A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy [Phase 2, Phase 3]